These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31778883)

  • 1. Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis.
    Arceo ES; Dizon GA; Tiongco REG
    Diabetes Metab Syndr; 2019; 13(6):3093-3097. PubMed ID: 31778883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
    Pabalan N; Tiongco RE; Pandac JK; Paragas NA; Lasta SL; Gallego N; Jarjanazi H; Pineda-Cortel MR
    PLoS One; 2018; 13(12):e0208905. PubMed ID: 30557306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy.
    Chen H; Li H
    Clin Lab; 2017 Feb; 63(2):241-247. PubMed ID: 28182344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Elsayed MS; El Badawy A; Ahmed A; Omar R; Mohamed A
    Diabetes Metab Syndr; 2019; 13(1):374-381. PubMed ID: 30641728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-Analysis.
    Zhou B; Zou H; Xu G
    Kidney Blood Press Res; 2016; 41(6):919-928. PubMed ID: 27889768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy.
    Siddiqi Z; Karoli R; Kaul A; Fatima J; Varshney S; Beg MS
    Ann Afr Med; 2017; 16(3):101-106. PubMed ID: 28671149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of glomerular filtration rate using cystatin C in diabetic patients analysed by multiple factors including tubular function.
    Zhang PP; Zhan JF; Xie HL; Li LS; Liu ZH
    J Int Med Res; 2010; 38(2):473-83. PubMed ID: 20515562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q; Wang M; Xu T; Liang W; Yang F
    J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
    Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
    Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients.
    Hassan M; Hatata EZ; Al-Arman M; Aboelnaga MM
    Diabetes Metab Syndr; 2021; 15(4):102152. PubMed ID: 34186366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis.
    Xin C; Xie J; Fan H; Sun X; Shi B
    Front Endocrinol (Lausanne); 2021; 12():766516. PubMed ID: 34867811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.